MIRA Pharmaceuticals, Inc. (MIRA) stock
MIRANasdaqPharmaceutical Preparations
$0.29−0.08 (-20.99%)
Close on Nov 20, 2026Market cap $12.23MP/E –Yield –
MIRA Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
MIRA Pharmaceuticals's cash was $8.11M at Jun 30, 2026. For fiscal 2025 it was $11.03M, up 289.4% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.03M | +289.4% |
| FY2024 | Dec 31, 2024 | $2.83M | -38.4% |
| FY2023 | Dec 31, 2023 | $4.60M | +1211.4% |
| FY2022 | Dec 31, 2022 | $350.98K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.11M | +1010.7% |
| Q1 FY2026 | Mar 31, 2026 | $4.67M | +287.3% |
| Q4 FY2025 | Dec 31, 2025 | $11.03M | +289.4% |
| Q3 FY2025 | Sep 30, 2025 | $7.54M | +81.8% |
| Q2 FY2025 | Jun 30, 2025 | $730.48K | -74.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.21M | -65.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.83M | -38.4% |
| Q3 FY2024 | Sep 30, 2024 | $4.14M | -29.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.82M | +11275.7% |
| Q1 FY2024 | Mar 31, 2024 | $3.53M | +905.4% |
| Q4 FY2023 | Dec 31, 2023 | $4.60M | – |
| Q3 FY2023 | Sep 30, 2023 | $5.87M | – |
| Q2 FY2023 | Jun 30, 2023 | $24.82K | – |
| Q4 FY2022 | Dec 31, 2022 | $350.98K | – |
See a number that looks wrong?